About Gary Kaltbaum
This author has yet to write their bio.Meanwhile lets just say that we are proud Gary Kaltbaum contributed a whooping 4745 entries.
Entries by Gary Kaltbaum
A $1.75 billion state loan for Putin son-in-law Shkreli’s former company files for bankruptcy ISIS suffers double blow as Ramadi falls Puerto Rico to default on some debts, will pay GO debt Brussels New Year fireworks canceled over attack fears Chicago mayor to announce changes to police policy after shootings
Investor's Edge: 12/30/2015Listen to today’s show by clicking here.
Stock Market Commentary: Stocks were relatively quiet on Wednesday as oil prices fell over 3%. Remember, oil is in a steep bear market and wild swings (up and down) are common in bear markets. Elsewhere, Pending home sales fell by 0.9%, missing estimates for a gain of 0.5%. This was the third decline in the past […]
Stock Market Overview: As of this writing (6:17am), U.S. stock futures are slightly lower on the second to last trading day of the year. Stocks bounced nicely on Tuesday, led by the usual suspects (big glamour names). Oil prices rebounded on Tuesday which also helped lift many beaten down areas of the market. Remember, this is […]
201 S Orange Ave.
Orlando , FL 32801
Toll Free: 888-422-5559
- WEEKEND NOTESSeptember 24, 2017 - 3:08 pm
Still, nothing in the way of even a 3% correction. Major indices, for the most part, remain in good shape. The DOW and S&P”s breakout from early last week remains intact. The NASDAQ and NDX remain in shape but we are now seeing some mega-cap names causing a little bit of lagging here. Names like […]
- RADIO SHOW 9/22September 23, 2017 - 10:10 am
- PRE MARKET- AND BIOTECH BLOW UPSeptember 22, 2017 - 9:41 am
Quiet! But again, market refuses to budge. Any weakness is sopped up. EASY MONEY RULES! Yellen stating she will roll back QE is laughable. Already said she would reprint if markets fall. Really? VSAR…as this is written, the stock is trading at $3…down $18.60. That is not a typo. Another BIOTECH with no sales with […]